8-K current report · filed Jul 14, 2026

XOMA Royalty Corp (XOMA) 8-K Current Report: July 14, 2026

Item 1.02Item 2.01Item 1.01Item 3.01Item 3.03Item 5.01Item 5.07Item 8.01Item 5.02XOMA overview

Short answer

XOMA Royalty Corp (XOMA) filed an 8-K current report with the SEC on July 14, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 1.01 (Entry into a Material Definitive Agreement), Item 3.01 (Notice of Delisting), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), Item 5.02 (Departure/Election of Directors or Officers). Holding-company reorganization preserved shareholders’ one-for-one common-stock ownership and converted equity awards on equivalent terms.

  • This filing includes Item 3.01, an item that often signal trouble.

Why these 8-K items matter →

XOMA Royalty Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Holding-company reorganization preserved shareholders’ one-for-one common-stock ownership and converted equity awards on equivalent terms
  • Company converted to Delaware LLC, separating operating assets and liabilities between HoldCo and XOMA Royalty LLC
  • HoldCo transferred 75% of XOMA Royalty LLC to XOMA CVR Trust for contingent value rights holders
  • CVRs issued pro rata to common and preferred shareholders, based on preferred shares converted to common
  • CVR payments depend on future distributions from the trust’s XOMA Royalty LLC interest, creating contingent rather than immediate consideration

Item 1.02 · Termination of a Material Definitive Agreement

  • XRL 1 LLC terminated its December 15, 2023 Loan Agreement in connection with the merger
  • Parent fully discharged all outstanding borrowing obligations on behalf of XOMA
  • Debt repayment removes the Loan Agreement and associated lender commitments from XOMA’s capital structure
  • Blue Owl Capital Corporation served as administrative agent for the lenders

Item 2.01 · Completion of Acquisition or Disposition of Assets

  • Merger completed July 14, 2026, taking XOMA private under Parent ownership
  • Common shareholders received $39.00 cash per share plus contingent value rights tied to XOMA Royalty LLC
  • 75% of XOMA Royalty LLC transferred to the CVR Trust, funding potential future CVR payments
  • 8.625% Series A and 8.375% Series B preferred stock redeemed, including accrued unpaid dividends
  • Holding company reorganization separated HoldCo business assets and liabilities from the royalty business

Item 3.01 · Notice of Delisting

  • Merger closing triggered XOMA share delisting from Nasdaq Global Market
  • Trading halt and delisting requested before July 14, 2026
  • Form 25 filing will remove Shares from Nasdaq and deregister them under Exchange Act Section 12(b)
  • Planned Form 15 filing would terminate Section 12(g) registration and suspend SEC reporting obligations
  • Shareholders should expect no further Nasdaq trading or regular public-company reporting after closing-related filings

Item 3.03 · Material Modification to Rights of Security Holders

  • Item 3.03 incorporates Items 2.01, 3.01 and 5.01, indicating security-holder rights may change through the reported transaction
  • Investor impact depends on the acquisition, exchange-listing and control-change details disclosed in those incorporated items

Item 5.01 · Changes in Control of Registrant

  • Item 5.01 contains no standalone control-change details
  • Investor impact depends on the referenced Introductory Note and Items 2.01 and 5.02 disclosures

Item 5.02 · Departure/Election of Directors or Officers

  • Merger Sub directors Todd C. Davis, Octavio Espinoza and Andrew Reardon now control XOMA’s board
  • Seven prior directors resigned, including Jack L. Wyszomierski, Heather L. Franklin and Matthew Perry
  • Former Merger Sub officers assumed XOMA executive roles at the merger effective time
  • Broad leadership turnover signals a post-merger governance reset and potential strategic shift

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Stockholders approved the merger agreement, holding-company reorganization, and related compensation proposal
  • Merger agreement: 15,924,106 votes for versus 98,100 against
  • Holding-company reorganization: 15,924,259 votes for versus 98,089 against
  • Compensation proposal: 15,745,257 votes for versus 272,303 against
  • Approval clears the shareholder-vote condition for the proposed transaction and corporate restructuring

Item 8.01 · Other Events

  • Closing of Parent’s acquisition of XOMA Royalty announced July 14, 2026
  • Transaction creates integration, execution and potential litigation risks for shareholders
  • Expected acquisition benefits may be delayed or fail to materialize
  • Royalty and pipeline value remains dependent on partners, clinical outcomes and regulatory approvals
  • Exhibit 99.1 contains the substantive closing announcement

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other XOMA Royalty Corp 8-K filings

Get the next XOMA 8-K as it lands

Follow XOMA for push alerts, or ask the research agent what this filing means.